What Researchers Did
Researchers examined 75 patients with medium-gravity viral hepatitis B to assess the effect of hyperbaric oxygenation (HBO) on disease progression and blood leukocyte reactions.
What They Found
Researchers found that hyperbaric oxygenation (HBO) administered during the first week of hospitalization favorably impacted 75 patients with viral hepatitis B, significantly reducing exacerbations and residual phenomena. HBO treatment led to a decrease in T and B lymphocytes by the 10th session and increased leukocyte functional metabolic activity. However, HBO used in weeks 4-5 showed no distinct clinical benefit.
What This Means for Canadian Patients
For Canadian patients with medium-gravity viral hepatitis B, this research suggests that early hyperbaric oxygenation (HBO) treatment could potentially reduce disease exacerbations and lingering symptoms. This approach might offer a prophylactic benefit, especially if patients are selected based on specific cytochemical tests.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A limitation of this study is the absence of a clearly defined control group for comparison and its single-center origin.